Fintel reports that on January 22, 2025, RBC Capital downgraded their outlook for Intra-Cellular Therapies (NasdaqGS:ITCI) ...

RBC Capital analyst Brian Abrahams maintained a Buy rating on Regeneron (REGN – Research Report) on January 21 and set a price target of ...

RBC Capital analyst Brian Abrahams maintained a Hold rating on Incyte (INCY – Research Report) on January 21 and set a price target of $70.00.

Global stocks eased on Thursday, halting a rally sparked by U.S. President Donald Trump's mammoth spending plans for ...

Fintel reports that on January 21, 2025, RBC Capital downgraded their outlook for CF Industries Holdings (NYSE:CF) from ...

Each year, RBC supports thousands of students from different educational backgrounds in exploring various career paths within ...

RBC Capital Markets sized up Shopify Inc. (NYSE:SHOP) ahead of the company's Q4 earnings report due out in a few weeks. Analyst Paul Treiber said data from several third-party sources indicates ...

CF Industries Holdings, Inc. (CF) stock saw a decline, ending the day at $93.66 which represents a decrease of $-3.35 or -3.45% from the prior close of $97.01. The stock opened at $95.5 and touched a ...

GE Aerospace (GE) is set to announce Q4 earnings, with analysts focused on engine deliveries, margins, and aftermarket growth ...

However, its 2025 costs and capital expenditure guidance exceeded analyst expectations as well as its own previous guidance. For full-year 2025, Hochschild expects capital expenditure between $197 ...

For 2024, core inflation averaged 2.4%, pulling back sharply from the 4.2% rate seen in 2023. The headline measure came in at 2.7% versus 4.8% in 2023, suggesting that policymakers' efforts to tame ...

Investing.com -- RBC Capital Markets has downgraded both Anglo American (JO: AGLJ) plc and Antofagasta (LON: ANTO) plc to ...